Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adcendo
Biotech
Adcendo signs $1B biobuck deal for Multitude's anti-TF ADC
Adcendo is the latest biotech to go big in an ADC deal, signing off on $1 billion in biobucks to get the ex-China rights to a preclinical candidate.
James Waldron
Aug 20, 2024 7:22am
Guth takes reins of Bayer’s US operations—Chutes & Ladders
Jun 23, 2023 9:30am
Biogen CEO steps down after Aduhelm blunder—Chutes & Ladders
May 6, 2022 9:30am
GSK oncology head leaves for biotech Scorpion—Chutes & Ladders
Jul 9, 2021 9:30am
Ex-Immunomedics CEO takes the wheel at Danish ADC player
Jul 7, 2021 10:35am
Adcendo raises €51M series A round to pursue 'ideal' ADC target
Apr 29, 2021 8:15am
